WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug ...Middle East

PR Newswire - Economy
WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug
Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov. 20, 2024 /PRNewswire/ -- WideTrial, an innovator of expanded access program (EAP) solutions, announced its participation in an NIH-funded collaboration...

Hence then, the article about widetrial supports nih funded expanded access program for investigational als drug was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy
OILPRICE - before 7 hours & 4 minute